Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Abstract Chemo‐immunotherapy has made significant progress in cancer treatment. However, the cancer cell self‐defense mechanisms, including cell cycle checkpoint and programmed cell death‐ligand 1 (PD‐L1) upregulation, have greatly hindered the therapeutic efficacy. Herein, norcantharidin (NCTD)‐pla...
Saved in:
| Main Authors: | Jiajia Xiang, Kexin Liu, Hongxia Xu, Zhihao Zhao, Ying Piao, Shiqun Shao, Jianbin Tang, Youqing Shen, Zhuxian Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-10-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202301216 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Programming Injectable DNA Hydrogels Yields Tumor Microenvironment‐Activatable and Immune‐Instructive Depots for Augmented Chemo‐Immunotherapy
by: Yu Fan, et al.
Published: (2023-10-01) -
Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis
by: Xinyan Hao, et al.
Published: (2025-01-01) -
Nanomedicine based on chemotherapy-induced immunogenic death combined with immunotherapy to enhance antitumor immunity
by: Yichang Chen, et al.
Published: (2024-12-01) -
Dual-drug loaded manganese dioxide nanoparticles coated with bacterial outer-membrane vesicles for chemo-immunotherapy in lung cancer
by: Lixu Xie, et al.
Published: (2024-11-01) -
Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma
by: I. C. Salaroglio, et al.
Published: (2024-12-01)